Proactive London's Andrew Scott chats to Arix Bioscience PLC's (LON:ARIX) chairman Naseem Amin who took on the role in April this year.
He discusses some of the recent significant changes at the group including its entrepreneur-in-residence, Christian Schetter, who's been appointed managing director of the venture capital company alongside Jonathan Tobin as well as the establishment of both a scientific advisory board (SAB) and a board investment committee (BIC).